1 / 8Citi on Punjab National Bank: The brokerage had a 'sell' call on the stock with the target price cut to Rs 40 from Rs 59 per share.
2 / 8Citi on Yes Bank: The brokerage revised rating to 'under review' from 'sell' given high uncertainties and price volatility.
3 / 8Citi on BPCL: The brokerage maintained a 'buy' call on the stock with the target at R 525 per share. It added that a 20 percent correction in the last one month provides an attractive entry point for investors.
4 / 8Morgan Stanley on Biocon: The brokerage had an 'overweight' call on the stock with the target price at Rs 355 per share.
5 / 8Morgan Stanley on IndiGo: The brokerage had an 'overweight' call on the stock with the target price of Rs 2,057 per share. The rising number of COVID-19 cases poses a risk to passenger traffic growth, it added.
6 / 8Kotak on Metals: The brokerage reduced FY21 EBITDA for steel companies by 8-11 percent. It also cut the target price for Tata Steel, JSPL, and JSW Steel.
7 / 8Credit Suisse on Financials: As per reports, SBI may step up capital infusion into Yes Bank to $1 billion, said the brokerage, adding that with other investors likely coming in, clean-up burden for the SBI will be lower.
8 / 8CLSA on Cadila Healthcare: The brokerage maintained a 'buy' call on the stock with the target at Rs 330 per share. It added that the FMCG business can deliver double-digit revenue growth.
